Amneal Pharmaceuticals, Inc.

Rating Overview

Amneal Pharmaceuticals, Inc. is Medium Risk.

Amneal Pharmaceuticals, Inc. is Medium Risk. The company often yields to political activism in shaping corporate governance, potentially alienating consumers, dividing employees, and harming shareholders. The company implements race and identity-based policies that replace merit, excellence, and integrity with preferential treatment and outcomes. The company occasionally embraces corporate initiatives that redirect its central focus from business goals to partisan policies and divisive issues at times. This approach fails to safeguard free exercise, free speech, and free enterprise.

Rating Criteria

Corporate Weaponization Risk Levels
Criteria	Risk Level
Cancellations	Medium Risk
Discriminatory Philanthropy	Lower Risk
Employment Protection	High Risk

Corporate Weaponization ⓘ

Corporate Governance and Public Policy Risk Levels
Criteria	Risk Level
Advocacy Bias	Medium Risk
Funding	Lower Risk
Political Actions	Lower Risk

Corporate Governance and Public Policy ⓘ

Rating Criteria Detail

Criteria Risk Level Rationale

Corporate Weaponization

Criteria:

Has canceled customers, suppliers, or vendors due to their political views or religious beliefs OR corporately boycotts, divests, or sanctions regions, people groups, or industries.

Risk Level:

Medium

Rationale:

Amneal Pharmaceuticals integrates ESG into its business practices. From its 2024 Business Responsibility Report: “The Nominating and Corporate Governance Committee assists the Board in fulfilling its oversight responsibilities with respect to the management of risks associated with corporate governance. This includes Board structure, size, membership and succession planning for our directors, as well as ESG matters of importance to the company. The Committee also assists in carrying out our commitment to ESG principles and diverse representation on our Board” Amneal Pharmaceuticals promotes divisive sex and gender policies. Its Global Supplier Code of Conduct requires international vendors to include sexual orientation and gender identity in their nondiscrimination policy (2). However, the company has not publicly canceled customers, suppliers, or vendors based on political views or religious beliefs (3).

Criteria:

Charitable giving (including employee matching programs) policies or practices discriminate against charitable organizations based on views or religious beliefs.

Risk Level:

Lower

Rationale:

Amneal Pharmaceuticals does not appear to discriminate against charitable organizations based on views or beliefs (1).

Criteria:

Employment policies fail to protect against viewpoint or other discrimination and/or are ideological in nature.

Risk Level:

High

Rationale:

Amneal Pharmaceuticals requires its employees to take unconscious bias training (1). Amneal Pharmaceuticals appears to prioritize diversity over merit in its leadership composition. From its Nominating and Corporate Governance Committee Charter: “the Committee will identify individuals qualified to become members of the Board and ensure that the Board has the requisite expertise and that its membership consists of persons with sufficiently diverse and independent backgrounds. In this regard, the Committee will conduct appropriate inquiries into the backgrounds and qualifications of possible candidates. The Committee will also recommend to the Board the nominees for election to the Board at the next annual meeting of shareholders” (2). However, the company does not provide viewpoint protections for its employees (3)(4).

Corporate Governance and Public Policy

Criteria:

Uses corporate reputation to support causes, organizations, or policies hostile to freedom of expression.

Risk Level:

Medium

Rationale:

Amneal Pharmaceuticals supports ESG within its business practices. From its 2024 Business Responsibility Report: “With this mission in mind, our ESG and Operations teams (including EHS and Engineering) began collaborating at a global scale in 2024. Members from all facilities across Ireland, India and the U.S. now connect regularly to discuss environmental and safety issues, initiatives and local progress, sharing insights and spurring innovation” Amneal Pharmaceuticals has not supported ideological causes or policies (2).

Criteria:

Uses corporate funds to advance ideological causes, organizations, or policies hostile to freedom of expression.

Risk Level:

Lower

Rationale:

Amneal Pharmaceuticals has not used corporate funds to advance ideological causes, organizations, or policies (1).

Criteria:

Uses corporate political actions and/or financial contributions for ideological, non-business purposes.

Risk Level:

Lower

Rationale:

Amneal Pharmaceuticals does not operate a PAC at this time and has not used its lobbying for ideological purposes (1)(2)(3).